https://www.selleckchem.com/pr....oducts/rbn013209.htm
In another work, we will address long-term monitoring, post-marketing authorization pharmacovigilance and issues relating to JACIE and regulatory authorities. These recommendations are not prescriptive; their aim is to provide guidelines for the use of this new therapeutic approach. The purpose of this workshop is to outline the organizational aspects of this new therapeutic approach.In a few situations, the consequences secondary to a carcinological pathology require an assessment of damages for compensatory purposes. This is particu
Curtir
Comentario
Compartilhar
